An Exploratory Study of NBI-34060 Capsules and Next Day Functioning

Withdrawn before enrolling · Phase 3

Conditions studied: Insomnia

In brief

NBI-34060 is an investigational (research) medication being studied in people with insomnia. The current study is designed to evaluate how people, who experience a nighttime awakening with difficulty returning to sleep, feel during the next day after dosing with NBI-34060. The study will also examine the pattern and extent of nighttime awakenings as reported by the patients, as well as and the patient's sleep experience during treatment.

Key facts

Study ID

NCT00525941

Run by

Neurocrine Biosciences

People needed

0

Starts

2007-09-01

Expected to finish

2008-01-01

Last updated by the study team

2015-05-12

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• insomnia (DSM-IV diagnosed; at least one month)
• Nocturnal awakenings
• Usual bedtimes between 9:00PM and Midnight.
• Bedtimes that do not vary by more than 2 hours on 5 or more nights per week.
• A usual time in bed of 7 to 9 hours.

You may not qualify if…

• no serious concomitant illness
• no other condition that could interfere with sleep

Where it is running

• Sleep Disorders Center of Georgia — Atlanta, Georgia, United States
• Clinilabs, Inc. — New York, New York, United States
• Community Research — Cincinnati, Ohio, United States
• Tri-State Sleep Disorders Center — Cincinnati, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.